O	O	O	0	15	Transcriptional	Transcriptional	B-NP	JJ	O	2	NMOD	O
O	O	O	16	21	basis	basis	I-NP	NN	O	0	ROOT	O
O	O	O	22	25	for	for	B-PP	IN	O	2	NMOD	O
O	O	O	26	44	hyporesponsiveness	hyporesponsiveness	B-NP	NN	O	3	PMOD	O
O	O	O	45	47	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	48	51	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	52	57	human	human	I-NP	JJ	B-DNA	12	NMOD	B-DNA
T1	B-Protein	B-Protein	58	67	inducible	inducible	I-NP	JJ	I-DNA	12	NMOD	I-DNA
T1	I-Protein	I-Protein	68	74	nitric	nitric	I-NP	JJ	I-DNA	12	NMOD	I-DNA
T1	I-Protein	I-Protein	75	80	oxide	oxide	I-NP	NN	I-DNA	12	NMOD	I-DNA
T1	I-Protein	I-Protein	81	89	synthase	synthase	I-NP	NN	I-DNA	12	NMOD	I-DNA
O	O	O	90	94	gene	gene	I-NP	NN	I-DNA	5	PMOD	I-DNA
O	O	O	95	97	to	to	B-PP	TO	O	4	NMOD	O
O	O	O	98	116	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	18	NMOD	O
O	O	O	116	117	/	/	B-NP	SYM	O	18	P	O
T2	B-Protein	B-Protein	117	127	interferon	interferon	I-NP	NN	B-protein	18	NMOD	B-protein
T2	I-Protein	I-Protein	127	128	-	-	B-NP	HYPH	I-protein	18	NMOD	I-protein
T2	I-Protein	I-Protein	128	133	gamma	gamma	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	O	133	134	.	.	O	.	O	2	P	O

O	O	O	136	139	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	140	144	work	work	I-NP	NN	O	5	SUB	O
O	O	O	145	153	reported	report	B-VP	VBN	O	2	NMOD	O
O	O	O	154	158	here	here	B-ADVP	RB	O	3	VMOD	O
O	O	O	159	167	resolves	resolve	B-VP	VBZ	O	0	ROOT	O
O	O	O	167	168	,	,	O	,	O	5	P	O
O	O	O	169	171	at	at	B-PP	IN	O	5	VMOD	O
O	O	O	172	175	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	176	181	level	level	I-NP	NN	O	7	PMOD	O
O	O	O	182	184	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	185	189	gene	gene	B-NP	NN	O	12	NMOD	O
O	O	O	190	200	regulation	regulation	I-NP	NN	O	10	PMOD	O
O	O	O	200	201	,	,	O	,	O	5	P	O
O	O	O	202	205	the	the	B-NP	DT	O	15	NMOD	O
O	O	O	206	217	controversy	controversy	I-NP	NN	O	5	OBJ	O
O	O	O	218	220	as	as	B-PP	IN	O	15	NMOD	O
O	O	O	221	223	to	to	B-PP	TO	O	16	PMOD	O
O	O	O	224	231	whether	whether	B-SBAR	IN	O	17	PMOD	O
O	O	O	232	234	or	or	O	CC	O	18	DEP	O
O	O	O	235	238	not	not	O	RB	O	18	DEP	O
O	O	O	239	244	human	human	B-NP	JJ	B-cell_type	22	NMOD	B-cell_type
O	O	O	245	254	monocytes	monocyte	I-NP	NNS	I-cell_type	24	NMOD	I-cell_type
O	O	O	254	255	/	/	B-NP	SYM	B-cell_type	24	NMOD	B-cell_type
O	O	O	255	266	macrophages	macrophage	B-NP	NNS	I-cell_type	25	SUB	I-cell_type
O	O	O	267	270	can	can	B-VP	MD	O	18	SBAR	O
O	O	O	271	278	produce	produce	I-VP	VB	O	25	VC	O
O	O	O	279	285	nitric	nitric	B-NP	JJ	O	28	NMOD	O
O	O	O	286	291	oxide	oxide	I-NP	NN	O	26	OBJ	O
O	O	O	292	293	(	(	O	(	O	31	DEP	O
O	O	O	293	295	NO	NO	B-NP	NN	O	31	DEP	O
O	O	O	295	296	)	)	O	)	O	28	NMOD	O
O	O	O	297	301	when	when	B-ADVP	WRB	O	25	VMOD	O
O	O	O	302	312	stimulated	stimulate	B-VP	VBN	O	32	SBAR	O
O	O	O	313	317	with	with	B-PP	IN	O	33	VMOD	O
O	O	O	318	336	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	34	PMOD	O
O	O	O	337	338	(	(	O	(	O	38	DEP	O
O	O	O	338	341	LPS	LPS	B-NP	NN	O	38	DEP	O
O	O	O	341	342	)	)	O	)	O	35	NMOD	O
O	O	O	342	343	,	,	O	,	O	33	P	O
O	O	O	344	348	with	with	B-PP	IN	O	33	VMOD	O
O	O	O	349	351	or	or	B-PP	CC	O	40	PMOD	O
O	O	O	352	359	without	without	B-PP	IN	O	40	PMOD	O
O	O	O	360	362	co	co	B-NP	AFX	O	45	NMOD	O
O	O	O	362	363	-	-	I-NP	HYPH	O	45	NMOD	O
O	O	O	363	374	stimulation	stimulation	B-NP	NN	O	40	PMOD	O
O	O	O	375	377	by	by	B-PP	IN	O	45	NMOD	O
T3	B-Protein	B-Protein	378	388	interferon	interferon	B-NP	NN	B-protein	49	NMOD	B-protein
T3	I-Protein	I-Protein	388	389	-	-	O	HYPH	I-protein	49	P	I-protein
T3	I-Protein	I-Protein	389	394	gamma	gamma	B-NP	SYM	I-protein	46	PMOD	I-protein
O	O	O	395	396	(	(	O	(	O	54	DEP	O
T4	B-Protein	B-Protein	396	399	IFN	IFN	B-NP	NN	B-protein	53	NMOD	B-protein
T4	I-Protein	I-Protein	399	400	-	-	O	HYPH	I-protein	53	P	I-protein
T4	I-Protein	I-Protein	400	405	gamma	gamma	B-NP	NN	I-protein	54	DEP	I-protein
O	O	O	405	406	)	)	O	)	O	49	NMOD	O
O	O	O	406	407	.	.	O	.	O	5	P	O

O	O	O	408	415	Studies	Study	B-NP	NNS	O	2	SUB	O
O	O	O	416	424	included	include	B-VP	VBD	O	0	ROOT	O
O	O	O	425	435	structural	structural	B-NP	JJ	O	4	NMOD	O
O	O	O	436	446	comparison	comparison	I-NP	NN	O	22	NMOD	O
O	O	O	447	449	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	450	453	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	454	463	promoters	promoter	I-NP	NNS	B-DNA	5	PMOD	B-DNA
O	O	O	464	467	for	for	B-PP	IN	O	7	NMOD	O
O	O	O	468	473	human	human	O	JJ	B-DNA	18	NMOD	B-DNA
O	O	O	474	477	and	and	O	CC	I-DNA	18	NMOD	I-DNA
O	O	O	478	483	mouse	mouse	B-NP	NN	I-DNA	18	NMOD	I-DNA
T5	B-Protein	B-Protein	484	493	inducible	inducible	I-NP	JJ	I-DNA	18	NMOD	I-DNA
T5	I-Protein	I-Protein	494	496	NO	NO	I-NP	NN	I-DNA	18	NMOD	I-DNA
T5	I-Protein	I-Protein	497	505	synthase	synthase	I-NP	NN	I-DNA	18	NMOD	I-DNA
O	O	O	506	507	(	(	O	(	I-DNA	18	NMOD	I-DNA
T6	B-Protein	B-Protein	507	511	iNOS	iNOS	B-NP	NN	I-DNA	18	NMOD	I-DNA
O	O	O	511	512	)	)	O	)	I-DNA	18	NMOD	I-DNA
T13	B-Entity	B-Entity	513	518	genes	gene	B-NP	NNS	I-DNA	8	PMOD	I-DNA
O	O	O	518	519	,	,	O	,	O	22	P	O
O	O	O	520	532	transfection	transfection	B-NP	NN	O	22	NMOD	O
O	O	O	533	536	and	and	O	CC	O	22	NMOD	O
O	O	O	537	542	assay	assay	B-NP	NN	O	2	OBJ	O
O	O	O	543	545	of	of	B-PP	IN	O	22	NMOD	O
O	O	O	546	551	human	human	B-NP	JJ	B-DNA	29	NMOD	B-DNA
O	O	O	552	555	and	and	I-NP	CC	I-DNA	29	NMOD	I-DNA
O	O	O	556	561	mouse	mouse	I-NP	NN	I-DNA	29	NMOD	I-DNA
T7	B-Protein	B-Protein	562	566	iNOS	iNOS	I-NP	NN	I-DNA	29	NMOD	I-DNA
T14	B-Entity	B-Entity	567	575	promoter	promoter	I-NP	NN	I-DNA	29	NMOD	I-DNA
T14	I-Entity	I-Entity	576	583	regions	region	I-NP	NNS	I-DNA	23	PMOD	I-DNA
O	O	O	584	586	in	in	B-PP	IN	O	22	NMOD	O
O	O	O	587	595	response	response	B-NP	NN	O	30	PMOD	O
O	O	O	596	598	to	to	B-PP	TO	O	31	NMOD	O
O	O	O	599	602	LPS	LPS	B-NP	NN	O	45	NMOD	O
O	O	O	603	604	+	+	O	SYM	O	45	NMOD	O
O	O	O	604	605	/	/	B-NP	SYM	O	45	NMOD	O
O	O	O	605	606	-	-	B-NP	HYPH	O	45	NMOD	O
T8	B-Protein	B-Protein	607	610	IFN	IFN	I-NP	NN	B-protein	45	NMOD	B-protein
T8	I-Protein	I-Protein	610	611	-	-	O	HYPH	O	45	P	O
T8	I-Protein	I-Protein	611	616	gamma	gamma	B-NP	SYM	O	45	NMOD	O
O	O	O	616	617	,	,	O	,	O	45	P	O
O	O	O	618	621	and	and	O	CC	O	45	NMOD	O
O	O	O	622	637	electrophoretic	electrophoretic	B-NP	JJ	O	45	NMOD	O
O	O	O	638	646	mobility	mobility	I-NP	NN	O	45	NMOD	O
O	O	O	647	652	shift	shift	I-NP	NN	O	45	NMOD	O
O	O	O	653	659	assays	assay	I-NP	NNS	O	32	PMOD	O
O	O	O	660	662	of	of	B-PP	IN	O	45	NMOD	O
T15	B-Entity	B-Entity	663	668	kappa	kappa	B-NP	NN	B-DNA	50	NMOD	B-DNA
T15	I-Entity	I-Entity	669	670	B	B	I-NP	NN	I-DNA	50	NMOD	I-DNA
T15	I-Entity	I-Entity	671	679	response	response	I-NP	NN	I-DNA	50	NMOD	I-DNA
T15	I-Entity	I-Entity	680	688	elements	element	I-NP	NNS	I-DNA	46	PMOD	I-DNA
O	O	O	688	689	.	.	O	.	O	2	P	O

O	O	O	690	693	Two	Two	B-NP	CD	O	2	NMOD	O
O	O	O	694	706	explanations	explanation	I-NP	NNS	O	18	SUB	O
O	O	O	707	710	for	for	B-PP	IN	O	2	NMOD	O
O	O	O	711	729	hyporesponsiveness	hyporesponsiveness	B-NP	NN	O	3	PMOD	O
O	O	O	730	732	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	733	736	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	737	742	human	human	I-NP	JJ	B-DNA	9	NMOD	B-DNA
T9	B-Protein	B-Protein	743	747	iNOS	iNOS	I-NP	NN	I-DNA	9	NMOD	I-DNA
T16	B-Entity	B-Entity	748	756	promoter	promoter	I-NP	NN	I-DNA	5	PMOD	I-DNA
O	O	O	757	759	to	to	B-PP	TO	O	4	NMOD	O
O	O	O	760	763	LPS	LPS	B-NP	NN	O	10	PMOD	O
O	O	O	764	765	+	+	O	SYM	O	17	NMOD	O
O	O	O	765	766	/	/	B-NP	SYM	O	17	NMOD	O
O	O	O	766	767	-	-	B-NP	HYPH	O	17	P	O
T10	B-Protein	B-Protein	768	771	IFN	IFN	I-NP	NN	B-protein	17	NMOD	B-protein
T10	I-Protein	I-Protein	771	772	-	-	B-NP	HYPH	O	17	P	O
T10	I-Protein	I-Protein	772	777	gamma	gamma	B-NP	SYM	O	11	NMOD	O
O	O	O	778	782	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	783	788	found	find	I-VP	VBN	O	18	VC	O
O	O	O	788	789	:	:	O	:	O	18	P	O
O	O	O	790	791	(	(	B-LST	(	O	22	DEP	O
O	O	O	791	792	1	1	I-LST	LS	O	27	NMOD	O
O	O	O	792	793	)	)	O	)	O	22	DEP	O
O	O	O	794	802	multiple	multiple	B-NP	JJ	O	25	AMOD	O
O	O	O	803	815	inactivating	inactivate	I-NP	VBG	O	27	NMOD	O
O	O	O	816	826	nucleotide	nucleotide	I-NP	NN	O	27	NMOD	O
O	O	O	827	840	substitutions	substitution	I-NP	NNS	O	60	NMOD	O
O	O	O	841	843	in	in	B-PP	IN	O	27	NMOD	O
O	O	O	844	847	the	the	B-NP	DT	O	31	NMOD	O
O	O	O	848	853	human	human	I-NP	JJ	O	31	NMOD	O
O	O	O	854	865	counterpart	counterpart	I-NP	NN	O	28	PMOD	O
O	O	O	866	868	of	of	B-PP	IN	O	31	NMOD	O
O	O	O	869	872	the	the	B-NP	DT	O	35	NMOD	O
T17	B-Entity	B-Entity	873	881	enhancer	enhancer	I-NP	NN	B-DNA	35	NMOD	B-DNA
T17	I-Entity	I-Entity	882	889	element	element	I-NP	NN	I-DNA	32	PMOD	I-DNA
O	O	O	890	894	that	that	B-NP	WDT	O	35	NMOD	O
O	O	O	895	898	has	have	B-VP	VBZ	O	36	SBAR	O
O	O	O	899	903	been	be	I-VP	VBN	O	37	VC	O
O	O	O	904	909	shown	show	I-VP	VBN	O	38	VC	O
O	O	O	910	912	to	to	I-VP	TO	O	41	VMOD	O
O	O	O	913	921	regulate	regulate	I-VP	VB	O	39	VMOD	O
O	O	O	922	925	LPS	LPS	B-NP	NN	O	46	NMOD	O
O	O	O	925	926	/	/	B-NP	SYM	O	46	P	O
T11	B-Protein	B-Protein	926	929	IFN	IFN	I-NP	NN	B-protein	46	NMOD	B-protein
T11	I-Protein	I-Protein	929	930	-	-	O	HYPH	I-protein	46	P	I-protein
T11	I-Protein	I-Protein	930	935	gamma	gamma	B-NP	SYM	I-protein	48	NMOD	I-protein
O	O	O	936	943	induced	induce	B-NP	VBN	O	48	NMOD	O
O	O	O	944	954	expression	expression	I-NP	NN	O	41	OBJ	O
O	O	O	955	957	of	of	B-PP	IN	O	48	NMOD	O
O	O	O	958	961	the	the	B-NP	DT	O	53	NMOD	O
O	O	O	962	967	mouse	mouse	I-NP	NN	B-DNA	53	NMOD	B-DNA
T12	B-Protein	B-Protein	968	972	iNOS	iNOS	I-NP	NN	I-DNA	53	NMOD	I-DNA
O	O	O	973	977	gene	gene	I-NP	NN	I-DNA	49	PMOD	I-DNA
O	O	O	977	978	;	;	O	:	O	60	P	O
O	O	O	979	982	and	and	O	CC	O	60	NMOD	O
O	O	O	983	984	(	(	B-LST	(	O	57	DEP	O
O	O	O	984	985	2	2	I-LST	LS	O	60	NMOD	O
O	O	O	985	986	)	)	O	)	O	57	DEP	O
O	O	O	987	990	and	and	O	CC	O	60	NMOD	O
O	O	O	991	998	absence	absence	B-NP	NN	O	18	VMOD	O
O	O	O	999	1001	of	of	B-PP	IN	O	60	NMOD	O
O	O	O	1002	1005	one	one	B-NP	CD	O	61	PMOD	O
O	O	O	1006	1008	or	or	I-NP	CC	O	62	AMOD	O
O	O	O	1009	1013	more	more	I-NP	JJR	O	62	AMOD	O
O	O	O	1014	1021	nuclear	nuclear	I-NP	JJ	B-protein	66	NMOD	B-protein
O	O	O	1022	1029	factors	factor	I-NP	NNS	I-protein	62	NMOD	I-protein
O	O	O	1030	1032	in	in	B-PP	IN	O	62	NMOD	O
O	O	O	1033	1038	human	human	B-NP	JJ	B-cell_type	69	NMOD	B-cell_type
O	O	O	1039	1050	macrophages	macrophage	I-NP	NNS	I-cell_type	67	PMOD	I-cell_type
O	O	O	1051	1052	(	(	O	(	O	88	DEP	O
O	O	O	1052	1053	e	e	B-NP	JJ	O	74	NMOD	O
O	O	O	1053	1054	.	.	I-NP	.	O	71	P	O
O	O	O	1054	1055	g	g	I-NP	NN	O	74	NMOD	O
O	O	O	1055	1056	.	.	I-NP	NN	O	87	NMOD	O
O	O	O	1056	1057	,	,	O	,	O	87	P	O
O	O	O	1058	1060	an	an	B-NP	DT	O	87	NMOD	O
T18	B-Entity	B-Entity	1061	1064	LPS	LPS	I-NP	NN	O	87	NMOD	O
T18	I-Entity	I-Entity	1064	1065	-	-	O	HYPH	O	87	P	O
T18	I-Entity	I-Entity	1065	1074	inducible	inducible	B-NP	JJ	O	84	NMOD	O
T18	I-Entity	I-Entity	1075	1082	nuclear	nuclear	I-NP	JJ	B-protein	84	NMOD	B-protein
T18	I-Entity	I-Entity	1083	1089	factor	factor	I-NP	NN	I-protein	84	NMOD	I-protein
T18	I-Entity	I-Entity	1089	1090	-	-	B-NP	HYPH	I-protein	84	NMOD	I-protein
T18	I-Entity	I-Entity	1090	1095	kappa	kappa	I-NP	NN	I-protein	84	NMOD	I-protein
T18	I-Entity	I-Entity	1096	1097	B	B	I-NP	NN	I-protein	87	NMOD	I-protein
T18	I-Entity	I-Entity	1097	1098	/	/	B-NP	SYM	O	87	P	O
T18	I-Entity	I-Entity	1098	1101	Rel	Rel	I-NP	NN	B-protein	87	NMOD	B-protein
T18	I-Entity	I-Entity	1102	1109	complex	complex	I-NP	NN	I-protein	88	DEP	I-protein
O	O	O	1109	1110	)	)	O	)	O	62	NMOD	O
O	O	O	1110	1111	,	,	O	,	O	62	P	O
O	O	O	1112	1116	that	that	B-NP	WDT	O	62	NMOD	O
O	O	O	1117	1119	is	be	B-VP	VBZ	O	90	SBAR	O
O	O	O	1120	1121	(	(	O	(	O	94	DEP	O
O	O	O	1121	1124	are	be	O	VBP	O	94	DEP	O
O	O	O	1124	1125	)	)	O	)	O	91	VMOD	O
O	O	O	1126	1134	required	require	B-VP	VBN	O	91	VC	O
O	O	O	1135	1138	for	for	B-PP	IN	O	95	VMOD	O
O	O	O	1139	1146	maximal	maximal	B-NP	JJ	O	98	NMOD	O
O	O	O	1147	1157	expression	expression	I-NP	NN	O	96	PMOD	O
O	O	O	1158	1160	of	of	B-PP	IN	O	98	NMOD	O
O	O	O	1161	1164	the	the	B-NP	DT	O	101	NMOD	O
O	O	O	1165	1169	gene	gene	I-NP	NN	O	99	PMOD	O
O	O	O	1169	1170	.	.	O	.	O	18	P	O

O	O	O	1171	1174	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	1175	1185	importance	importance	I-NP	NN	O	8	SUB	O
O	O	O	1186	1188	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	1189	1199	resolution	resolution	B-NP	NN	O	3	PMOD	O
O	O	O	1200	1202	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	1203	1207	this	this	B-NP	DT	O	7	NMOD	O
O	O	O	1208	1219	controversy	controversy	I-NP	NN	O	5	PMOD	O
O	O	O	1220	1222	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	1223	1227	that	that	B-SBAR	IN	O	8	PRD	O
O	O	O	1228	1234	future	future	B-NP	JJ	O	11	NMOD	O
O	O	O	1235	1243	research	research	I-NP	NN	O	15	SUB	O
O	O	O	1244	1246	in	in	B-PP	IN	O	11	NMOD	O
O	O	O	1247	1251	this	this	B-NP	DT	O	14	NMOD	O
O	O	O	1252	1256	area	area	I-NP	NN	O	12	PMOD	O
O	O	O	1257	1263	should	should	B-VP	MD	O	9	SBAR	O
O	O	O	1264	1266	be	be	I-VP	VB	O	15	VC	O
O	O	O	1267	1275	directed	direct	I-VP	VBN	O	16	VC	O
O	O	O	1276	1282	toward	toward	B-PP	IN	O	17	VMOD	O
O	O	O	1283	1286	the	the	B-NP	DT	O	20	NMOD	O
O	O	O	1287	1300	understanding	understanding	I-NP	NN	O	18	PMOD	O
O	O	O	1301	1303	of	of	B-PP	IN	O	20	NMOD	O
O	O	O	1304	1315	alternative	alternative	B-NP	JJ	O	23	NMOD	O
O	O	O	1316	1326	mechanisms	mechanism	I-NP	NNS	O	21	PMOD	O
O	O	O	1327	1331	that	that	B-NP	WDT	O	23	NMOD	O
O	O	O	1332	1335	can	can	B-VP	MD	O	24	SBAR	O
O	O	O	1336	1342	result	result	I-VP	VB	O	25	VC	O
O	O	O	1343	1345	in	in	B-PP	IN	O	26	VMOD	O
O	O	O	1346	1349	the	the	B-NP	DT	O	30	NMOD	O
O	O	O	1350	1360	successful	successful	I-NP	JJ	O	30	NMOD	O
O	O	O	1361	1371	production	production	I-NP	NN	O	27	PMOD	O
O	O	O	1372	1374	of	of	B-PP	IN	O	30	NMOD	O
O	O	O	1375	1377	NO	NO	B-NP	NN	B-protein	31	PMOD	B-protein
O	O	O	1377	1378	.	.	O	.	O	8	P	O
